PARTICULATE matter exposure significantly increases clinical disease activity and heightens the risk of rheumatoid arthritis flares.
Environmental factors are well recognized in the pathogenesis of autoimmune conditions, yet their direct impact on disease fluctuations in established cases remains incompletely understood. A prospective cohort study involving 1,070 patients with rheumatoid arthritis across 12,583 outpatient visits evaluated the longitudinal relationships between ambient air pollutants and clinical disease outcomes. Researchers tracked monthly concentrations of sulfur dioxide, nitrogen dioxide, ozone, carbon monoxide, coarse particulate matter, and fine particulate matter PM2.5 alongside clinical evaluations recorded between 2021 and 2024.
Among all six evaluated pollutants, PM2.5 demonstrated the strongest and most consistent association with disease exacerbations. Multivariate generalized estimating equation models revealed that higher PM2.5 levels significantly increased the risk of rheumatoid arthritis flares (adjusted odds ratio: 1.113, 95% confidence interval: 1.017 to 1.218). Furthermore, elevated PM2.5 exposure correlated directly with higher Disease Activity Score in 28 joints with C-reactive protein, elevated Clinical Disease Activity Index scores, and increased counts of both tender and swollen joints.
Subgroup analyses demonstrated that the association between PM2.5 and elevated disease activity was significantly more pronounced in female patients, nonsmokers, and individuals with higher baseline tender joint counts. Nonsmokers may exhibit heightened sensitivity to particulate matter because their pulmonary tissue lacks the chronic inflammatory saturation caused by cigarette smoke, leaving systemic pathways more susceptible to oxidative stress. Fine particulate matter can translocate from alveolar capillaries into systemic circulation, triggering reactive oxygen species generation, nuclear factor kappa B activation, and downstream proinflammatory cytokine production that amplifies synovial joint inflammation.
Sensitivity analyses employing a case-crossover design established that transient daily spikes were less impactful than sustained exposure. Cumulative PM2.5 exposure exceeding two weeks was required to produce a statistically significant increase in flare likelihood, demonstrating a clear dose-dependent trajectory. Healthcare providers managing autoimmune diseases should recognize air pollution as a modifiable clinical variable and encourage patients to monitor ambient air quality reports to mitigate potential environmental triggers of rheumatoid arthritis flares.
Reference
Jung SC et al. Effects of air pollution on disease activity in patients with rheumatoid arthritis. Ann Rheum Dis. 2026;doi:10.1016/j.ard.2026.06.018.
Featured Image: Leonid on Adobe Stock.
Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.
